← Back
Data updated: Mar 10, 2026
ALMAJECT
Infectious DiseaseDermatology
ALMAJECT is a generic drug manufacturer focused on Infectious Disease, Dermatology. Key products include VORICONAZOLE.
1987
Since
5
Drugs
-
Trials
72
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
DOXORUBICIN HYDROCHLORIDE 2026-02-03
TERIPARATIDE 2025-12-12
VORICONAZOLE 2025-11-14
VORICONAZOLE 2025-10-23
Labeling
VORICONAZOLE 2025-10-23
Labeling
VORICONAZOLE 2025-09-30
Labeling
VORICONAZOLE 2025-09-30
Labeling
VORICONAZOLE 2025-09-26
Labeling
VORICONAZOLE 2025-09-16
Labeling
VORICONAZOLE 2025-08-25
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Infectious Disease 50%
1 drugs
Dermatology 50%
1 drugs
Pipeline Strength Pro
Loading...
Active (3)
Discontinued (2)
Company Info
- First Approval
- 1987-07-24
- Latest
- 2025-07-09
- Applications
- 7